Japanese Encephalitis Vaccines: Current Vaccines and Future Prospects (original) (raw)
ACIP (Advisory Committee on Immunization Practices) (1993) Inactivated Japanese encephalitis vaccine. Morb Mort Wkly Rep (MMWR) 42RR-1: 1–15 Google Scholar
Aihara S, Rao CM, Yu YX (1991) Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process. Virus Genes 5: 95–109 ArticlePubMedCAS Google Scholar
Aihara H, Takasaki T, Matsutani T, Suzuki R, Kurane I (1998) Establishment and characterization of Japanese encephalitis virus-specific, human CD4+ T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity. J Virol 72: 8032–8036 PubMedCAS Google Scholar
Allison SL, Schalich J, Stiasny K, Mandl C, Kunz C, Heinz FX (1995) Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol 69: 695–700 PubMedCAS Google Scholar
Andersen MM, Ronne T (1991) Side-effects with Japanese encephalitis vaccine. Lancet 337: 1044 ArticlePubMedCAS Google Scholar
Arroyo J, Guirakhoo F, Fenner S, Zhang Z-X, Monath TP, Chambers TJ. (2001) Molecular Basis for Attenuation of Neurovirulence of a Yellow Fever/Japanese Encephalitis ( ChimeriVax-JE) Viral Vaccine. J Virol 75: 934–42 ArticlePubMedCAS Google Scholar
Berg SW, Mitchell BS, Hanson RK, Olafson RP, Williams RP, Tueller JE, Burton JR, Novak DM, Tsai TF, Wignall FS (1997) Systemic reactions in US Marine Corps personnel who received Japanese encephalitis vaccine. J Infect Dis 24: 265–266 ArticleCAS Google Scholar
Bhatt TR, Crabtree MB, Guirakhoo F, Monath TP, Miller BR (2001) Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax–JE (YF/JE SA14–14–2). in Culex tritaeniorhvnchus, Aedes albopictus and Aedes aegypti mosquitoes. Am J Trop Med Hyg 62: 480 – 84 Google Scholar
Burke DS, Leake CJ (1988) Japanese encephalitis. In: Monath TP (ed) The Arboviruses: Epidemiology and Ecology. Vol. 3. Boca Raton, FL, CRC Press. pp 63–92 Google Scholar
Camenga DL, Nathanson N, Cole GA (1974) Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J Infect Dis 130: 634–641 ArticlePubMedCAS Google Scholar
Chambers Ti, Nestorowicz A, Mason PW, Eckels KH, Rice CM (1999) Yellow fever/Japanese encephalitis chimaeric viruses: construction and biological properties. J Virol 73: 3095–3101 PubMedCAS Google Scholar
Chambers TJ, Tsai TF, Pervikov Y, Monath TP (1997) Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. Vaccine 15: 1494–1502 ArticlePubMedCAS Google Scholar
Chen BQ, Beaty BJ (1982) Japanese encephalitis vaccine (2–8 strain) and parent (SA14 strain) in Culex tritaeniorhynchus mosquitoes. Am J Trop Med Hyg 31: 403–407 PubMedCAS Google Scholar
Chen WR, Tesh RB, Rico-Hesse R (1990) Genetic variation of Japanese encephalitis virus in nature. J Gen Virol 71: 2915–2920 ArticlePubMedCAS Google Scholar
Chen WR, Rico-Hesse R, Tesh RB (1992) A new genotype of Japanese encephalitis virus from Indonesia. Am J Trop Med Hyg 47: 61–69 PubMedCAS Google Scholar
Chen L-K, Lin Y-L, Liao C-L, Lin C-G, Huang Y-L, Yeh C-T, Lai S-C, Jan J-T, Chin C (1996) Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro. Virology 223: 79–88 ArticlePubMedCAS Google Scholar
Chen HW, Pan CH, Liau MY, Jou R, Tsai CJ, Wu HJ, Lin YL (1999) Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional vaccines. J Virol 73: 10137–10145 PubMedCAS Google Scholar
Davis B, Chang G-J, Cropp B, Roehrig JT, Martin DA, Mitchell CJ, Bowen R, Bunning ML (2001) West Nile recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J Virol 75: 4040–4047 ArticlePubMedCAS Google Scholar
DeFraites RF (1991–1992) Immunogenicity and safety of Japanese encephalitis vaccine in US Army soldiers. Evaluation of three consecutively bmanufactured lots of vaccine administered in two dosing regimens. Cited in Japanese Encephalitis Virus Vaccine Inactivated JE-VAX, Product Information 1997 Google Scholar
Ding Z, Shi H, Pang C (1998) Production of purified Japanese encephalitis vaccine from Vero cells with roller bottles. Chung Hua I Hsueh Tsa Chin 78: 261–262 CAS Google Scholar
Governdhan MK, Kulkarni AB, Gupta AK, Tupe CD, Rodrigues JJ (1972) Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques. Acta Virol 36: 277–283 Google Scholar
Granoff DM, Rathore MH, Holmes SJ, et al. (1993) effect of immunity to the carrier protein on antibody responses to Haempophilns influenzae type b conjugate vaccines. Vaccine 11 (Suppl 1 ): S46 - S51 ArticlePubMedCAS Google Scholar
Guirakhoo F, Zhang Z, Chambers TJ, Delagrave S, Arroyo J, Barrett ADT, Monath TP (1999) Immunogenicity, genetic stability and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus ( Chimerivax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology 257: 363–372 Article Google Scholar
Guirakhoo F, Weltzin R, Chambers TJ, Zhang ZX, Soike K, Ratterree M, Arroyo J, Georgakopoulos K, Catalan J, Monath TP (2000) Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol 74: 5477–85 ArticlePubMedCAS Google Scholar
Halstead SB, Grosz CR. Subclinical Japanese encephalitis. 1. Infection of Americans with limited residence in Korea. Am J Hyg 75: 190–201 1962 PubMedCAS Google Scholar
Harrington DG, Hilmas DE, Elwell MR, Whitmire RE, Stephen EL (1977) Intranasal infection of monkeys with Japanese encephalitis virus: clinical response and treatment with a nuclease-resistant derivative of poly(I)-poly)C) Am J Trop Med Hyg 26: 1191–1198 PubMedCAS Google Scholar
Hasegawa T, Yoshida M, Kobayashi Y, Fujita S (1995) Antigenic analysis of Japanese encephalitis viruses in Asian by using monoclonal antibodies. Vaccine 13: 1713–1721 ArticlePubMedCAS Google Scholar
Hennessy S, Zhengle L, Tsai TF, Strom BL, Chao–Min W, Hui–Lian L, Tai–Xiang W, Hong–Ji Y, Qi–Mau L, Karabatsos N, Bilker WB, Halstead SB (1996) Effectiveness of live–attenuated Japanese encephalitis vaccine (SA14–14–2): a case–control study Lancet 347: 1583 – 1586 ArticlePubMedCAS Google Scholar
Hoke CH Jr, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, et al. (1988) Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319: 608–614 ArticlePubMedCAS Google Scholar
Igarashi A (1992) Epidemiology and control of Japanese encephalitis. World Health Stat Q 45 (2–3): 299–305 PubMedCAS Google Scholar
Jan L-R, Yueh Y-Y, Wu Y-C, Horng C-B, Wang G-R (2000) Genetic variation of Japanese encephalitis virus in Taiwan. Am J Trop Med Hyg 62: 446–452 PubMedCAS Google Scholar
Jennings AD, Gibson CA, Miller BR, Mathews JH, Mitchell CJ, Roehrig JT, Wood DJ, Taffs F, Sil BK, Whitby SN, Monath TP, Minor PD, Sanders PG, Barrett ADT (1994) Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis 169: 512–518 ArticlePubMedCAS Google Scholar
Jiang WR, Lowe A, Higgs S, Reid H, Gould EA (1993) Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced virulence. J Gen Virol 74: 931–935 ArticlePubMedCAS Google Scholar
Kanamitsu M, Hashimoto N, Urasawa S, Katsurada M, Kimura H (1970) A field trial with an improved Japanese encephalitis vaccine in a nonendemic area of the disease. Biken J 13: 313–328 PubMedCAS Google Scholar
Kanesa-Thasen N, Smucny JJ, Hoke CH Jr, Marks DH, Kpnishi E, Kurane I, Tang DB, Vaughn DW, Mason PW, Shope RE (2000) Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus-poxvirus vaccines in vaccinia non-immune and vaccinia-immune humans. Vaccine 19: 483–491 Article Google Scholar
Khang G, Cho JC, Lee JW, Rhee JM, Lee HB (1999) Preparation and characterization of Japanese encephalitis virus vaccine loaded ply(L-lactide-co-glycolide) microspheres for oral immunization. Biomed Mater Eng 9: 49–59 PubMedCAS Google Scholar
Kitano T, Yabe S, Kobayashi M. et al. (1986) Immunogenicity of JE Nakayama and Beijing-I vaccines. JE HFRS Bull 1: 37–41 Google Scholar
Kolaskar AS, Kulkarni-Kale U (1999) Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus. Virology 261: 31–42 ArticlePubMedCAS Google Scholar
Konishi E, Pincus S, Fonseca BAL, Shope RE, Paoletti E, et al. (1991) Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NSI of Japanese encephalitis virus. Virology 185: 401–410 CAS Google Scholar
Konishi E, Pincus S, Paoletti E, Laegreid WW, Shope RE, et al. (1992) A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology 190: 454–458 CAS Google Scholar
Konishi E, Pincus S, Paoletti E, Shope RE, Mason PW (1994) Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens. Vaccine 12: 633–638 ArticlePubMedCAS Google Scholar
Konishi E, Kurane I, Mason PW, Innis BL, Ennis FA (1995) Japanese encephalitis virus—specific proliferative responses of human peripheral blood T lymphocytes. Am J Trop Med Hyg 53: 278–283 PubMedCAS Google Scholar
Konishi E, Win KS, Kurane I, Shpoe RE, Ennis FA (1997) Particulate vaccine candidate for Jpanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice. Vaccine 15:281–286 ArticlePubMedCAS Google Scholar
Konishi E, Yamaoka M, Khin-Sane-Win, Kurane I, Mason PW (1998a) Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J Virol 72: 4925–4930 CAS Google Scholar
Konishi W E, Kurane I, Mason PW et al. (1998b) Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates. Vaccine 16: 842–849 ArticlePubMedCAS Google Scholar
Konishi E, Yamaoka M, Kurane I, Mason PW (2000) Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes indce virus-specific memory B cells and long-lasting antibodies in swine. Virology 268: 49–55 ArticlePubMedCAS Google Scholar
Lee HW, Scherer WF (1961) The anamnestic antibody response to Japanese encephalitis virus in monkeys and its implications concerning naturally acquired immunity in man. J Immunol 86: 151–164 PubMedCAS Google Scholar
Liu ZL, Hennessy S, Strom BL, et al. (1997) Short–term safety of live attenuated Japanese encephalitis vaccine (SA14–14–2): Results of a 26.239–subject randomized trial. J Infect Dis 176: 1366 – 1369 ArticlePubMedCAS Google Scholar
Long AP, Hullinghorst RL, Gauld RL (1954) Japanese B encephalitis–Korea 1950. Army Medical Science Graduate School Medical Science Publ. No. 4. Recent Adv Med Surg 2: 317–329 Google Scholar
Lubiniecki AS, Cypess RH, Hammon W McD (1973) Passive immunity for arbovirus infection. II. Quantitative aspects of naturally and artificially acquired protection in mice for Japanese ( B) encephalitis virus. Am J Trop Med Hyg 22: 535–542 Google Scholar
Ma X, Yu YX. Wang SG (1993) Observations on safety and serological efficacy from a large–scale field trial of Japanese encephalitis vaccine. Chin J Biol 6: 188–191 Google Scholar
Markoff L (2000) Points to consider in the development of a surrogate fro efficacy of novel Japanese encephalitis virus vaccines. Vaccine 18 (Suppl 2): 26–32 ArticlePubMedCAS Google Scholar
Mason PW, Pincus S, Fournier MJ, Mason TL, Shope RE. et al. (1991) Japanese Encephalitis VirusVaccinia Recombinants Produce Particulate Forms of the Structural Membrane Proteins and Induce High levels of Protection against Lethal JEV Infection. Virology 180: 294–305 ArticlePubMedCAS Google Scholar
Mathur A, Arora KL, Chaturvedi UC (1983) Host defense mechanisms against Japanese encephalitis cirus infection in mice. J Gen Virol 64: 805–811 ArticlePubMed Google Scholar
Monath TP, Levenbook I, Soike K. Zhang Z-X, Ratterree M. Draper K, Barrett ADT, Nichols R, Weltzin RA. Arroyo J, Guirakhoo F (2000) Live, attenuated recombinant chimeric yellow fever Japanese encephalitis vaccine: extended safety and immunogenicity studies in rhesus monkeys. J Virol 74: 1742–1751 ArticlePubMedCAS Google Scholar
Monath TP, Soike K, Levenbook I, Zhang Z–X, Arroyo J, Delagrave S, Myers G. Barrett ADT, Shope RE, Chambers TJ, Guirakhoo F (1999) Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA 14–14–2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in nonhuman primates. Vaccine 17: 1869 – 1882 ArticlePubMedCAS Google Scholar
Morris JA, Connor JR, Smadel JE (1955) Infection and immunity patterns in monkeys injected with viruses of Russian spring-summer and Japanese encephalitis. Am J Hyg 62: 327–341 PubMedCAS Google Scholar
Nazareth B, Levin J, Johnson H, Begg N (1994) Systemic allergic reactions to Japanese encephalitis vaccine. Vaccine 12: 666 ArticlePubMedCAS Google Scholar
Ni H, Barrett ADT (1998) Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants. Virology 241: 30–36 ArticlePubMedCAS Google Scholar
Ni H, Burns NJ, Cheng GJ, Zhang M-J, Wills MR, Trent DW, Sanders PG, Barrett ADT (1995) Comparison of nucleotide and deduced amino acid sequence of the 5’ non-coding region and struvtural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. J Gen Virol 75: 1505–1510 Article Google Scholar
Ni H, Cheng GJ, Xie H, Trent DW, Barrett ADT (1995) Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J Gen Virol 76: 409–413 ArticlePubMedCAS Google Scholar
Nitayaphan S, Grant JG, Chang GJ, Trent DW (1990) Nucleotide sequence of virulent SA14 strain of Japanese encephalitis and its attenuated derivative. Virology 177: 541–552 ArticlePubMedCAS Google Scholar
Ohtaki E, Matsuishi T. Hirano Y, Maekawa K (1995) Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination. J Neurol Neurosurg Psych 59: 316–317 ArticleCAS Google Scholar
Ozaki Y, Tabeyi K (1967) Studies on the neutralization of Japanese encephalitis virus. I. Application of kinetic neutralization to the measurement of the neutralizing potency of antiserum. J Immunol 98: 1218–1223 PubMedCAS Google Scholar
Oya A (1988) Japanese encephalitis vaccine. Acta Pediatr Jpn 30: 175 CAS Google Scholar
Plesner AM, Soborg PA, Herning AI (1996) Neurological complications and Japanese encephalitis vaccination. Lancet 348: 202–203 ArticlePubMedCAS Google Scholar
Plesner AM, Ronne T (1997) Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine 15: 1239–1243 ArticlePubMedCAS Google Scholar
Plesner, AM, Ronne T, Wachman H (2000) Case-control study of allergic reactions to Japanese encephalitis vaccine. Vaccine 18: 1830–1836 ArticlePubMedCAS Google Scholar
Poland JD, Cropp, CB, Craven, RB, Monath, TP (1990) Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US citizens. J Infect Dis 161: 878–882 ArticlePubMedCAS Google Scholar
Pond WL, Smadel JE (1954) Neurotropic viral diseases in the Far East during the Korean War. Army Medical Science Graduate School Medical Science Pub. No. 4. Recent Adv Med Surg 2: 219–233 Google Scholar
Raengsakulrach B, Nisalak A, Gettayacamin M, Thirawuth V, Young GD, Myint KS, Ferguson LM, Hoke CH Jr, Innis BL, Vaughn DW (1999a) Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinanat Japanese encephalitis vaccines in rhesus monkeys. Am J Trop Med Hyg 60: 343–349 PubMedCAS Google Scholar
Raengsakulrach B, Nisalak A, Gettayacamin M, Thirawuth V, Young GD, Myint KS, Ferguson LM, Hoke CH Jr, Innis BL, Vaughn DW (1999b) An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys. Am J Trop Med Hyg 60: 329–337 PubMedCAS Google Scholar
Ramakrishna C, Desai A, Shankar SK, Chandramuki A, Ravi I (1999) Oral immunization of mice with live Japanese encephalitis virus induces a protective immune response. Vaccine 17: 3102–3108 ArticlePubMedCAS Google Scholar
Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375: 291–298 ArticlePubMedCAS Google Scholar
Robinson P, Ruff T, Kass R (1995) Australian case-control study of adverse reactions to Japanese encephalitis vaccine. J Travel Medicine 2: 159–164 Article Google Scholar
Ruff TA, Eisen D, Fuller A, Kass R (1991) Adverse reactions to Japanese encephalitis vaccine. Lancet 338: 881–882 ArticlePubMedCAS Google Scholar
Sakaguchi M, Yoshida M, Kuroda W, Harayama O, Matsunaga Y, Inouye S (1997) Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines. Vaccine 15: 121–122 ArticlePubMedCAS Google Scholar
Sakaguchi M, Inouye S (1998) Two patters of systemic immediate-type reactions to Japanese encephalitis vaccines. Vaccine 16: 68–69 ArticlePubMedCAS Google Scholar
Siraprapasiri T, Sawaddiwudhipong W, Rojanasuphot S (1997) Cost benefit analysis of Japanese encephalitis vaccination program in Thailand. Southeast Asian J Trop Med Public Health 28: 143–148 PubMedCAS Google Scholar
Sohn YM, Park MS, Rho HO, Chandler U, Shope RE, Tsai TF (1999) Primary and boster immune responses to SA14–14–2 Japanese encephalitis vaccine in Korean infants. Vaccine 17: 2259 – 2264 ArticlePubMedCAS Google Scholar
Sumiyoshi H, Tignor GH, Shope RE (1995) Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA. J Infect Dis 171: 1144–1151 ArticlePubMedCAS Google Scholar
Sweet BH, Wisseman Jr CJ, Kitaoka M (1962) Immunological studies with group B arthropod-borne viruses. II. Effect of prior infection with Japanese encephalitis virus on the viremia in human subject following administration of 17D yellow fever vaccine. Am J Trop Med Hyg 11: 562–572 Google Scholar
Takaku IK, Yamashita T, Osanai T (1968) Japanese encephalitis purified vaccine. Biken J 11: 25–39 Google Scholar
Tsai TF, Yong–Xin Y, Li JL, Putvatana R, Ran Z, Shougui W, Halstead SB (1998) Immunogenicity of live attenuated SA14–14–2 Japanese encephalitis vaccine–A comparison of I– and 3–month immunization schedules. J Infect Dis 177: 221 – 223 ArticlePubMedCAS Google Scholar
Tsai TF (2000) New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine 18 (Suppl 2): 1–25 ArticlePubMed Google Scholar
Tsai TF, Chang G-J, Yu Y-X (1999) Japanese encephalitis vaccines. WB Saunders and Company, Philadelphia, pp 672–710 Google Scholar
Tsarev SA. Sanders NL. Vaughn DW, Innis BL (2000) Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus. Vaccine 18 (Suppl 2): 36–43 ArticlePubMedCAS Google Scholar
Yu YX, Wu PF, Ao J, Liu LH, Li HM (1981) Selection of a better immunogenic and highly attenuated live vaccine virus strain of JE. I. Some biological characteristics of SA14–14–2 mutant. Chin J M icro bio l I mm unol 1: 77 – 84 Google Scholar
Yu YX, Ming AG, Pen GY, et al. (1988) Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14–14–12) for children. Am J Trop Med Hyg 39: 214–217 Google Scholar
Yu YX, Zhang GM, Zheng Z (1989) Studies on the immunogenicity of live and killed Japanese encephalitis ( JE) vaccines to challenge with different Japanese encephalitis virus strains. Chin J Virol 5: 106–110 Google Scholar